BI-905677

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameBI-905677

Drug Alias NameBI-905677

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionLow-density lipoprotein receptor-related protein 5 inhibitorsLow-density lipoprotein receptor-related protein 6 inhibitorsWnt signalling pathway inhibitors

TargetsLow-density lipoprotein receptor-related protein 5Low-density lipoprotein receptor-related protein 6

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNetherlandsSpain +[4]

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A